| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/24/2005 | US20050260211 Drug delivery; delivering a non-cytotoxic therapeutic moiety into nerve cells; nerve growth factor |
| 11/24/2005 | US20050260204 interleukin-9 (IL-9); exhibit stability, low to undetectable levels of aggregation; storage stability; autoimmune, inflammatory, proliferative, respiratory diseases |
| 11/24/2005 | US20050260189 Microbubble compositions, and methods for preparing and using same |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260160 use of gene therapy in the treatment of aseptic loosening of orthopaedic prostheses; adenoviral vectors and prodrugs are used for simultaneous, separate or sequential destruction of interface tissue allowing subsequent recementing of loose prostheses in a minimally invasive manner |
| 11/24/2005 | US20050260153 Facilitation of iontophoresis using charged moieties |
| 11/24/2005 | US20050260145 Oil soluble compositions |
| 11/24/2005 | US20050260132 Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta |
| 11/24/2005 | DE102004020721A1 Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren Dermally applicable liquid formulations for controlling parasitic insects on animals |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2607206A1 Transdermal administration of phycotoxins |
| 11/24/2005 | CA2571320A1 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 11/24/2005 | CA2566364A1 Hydrogel interferon formulations |
| 11/24/2005 | CA2566190A1 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 11/24/2005 | CA2566188A1 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 11/24/2005 | CA2566185A1 Formulations with controlled release of active ingredient |
| 11/24/2005 | CA2565424A1 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | CA2565168A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same |
| 11/24/2005 | CA2563311A1 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | CA2562948A1 Enhanced biologically active conjugates |
| 11/24/2005 | CA2562572A1 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 11/24/2005 | CA2562569A1 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 11/24/2005 | CA2562499A1 Nucleotide-cochleate compositions and methods of use |
| 11/24/2005 | CA2508065A1 Antiproliferative drug and delivery device |
| 11/24/2005 | CA2507712A1 Pharmaceutical compounds |
| 11/23/2005 | EP1598419A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 11/23/2005 | EP1598365A1 Protection of endogenous therapeutic peptides |
| 11/23/2005 | EP1598081A2 Conjugates of a water-soluble amino acid polymer and a drug |
| 11/23/2005 | EP1598080A1 Seamless capsule |
| 11/23/2005 | EP1598074A1 Stabilized preparation containing protein |
| 11/23/2005 | EP1598061A1 Intraorally rapidly disintegrable tablet |
| 11/23/2005 | EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 11/23/2005 | EP1597318A1 Poloxamer emulsion preparations |
| 11/23/2005 | EP1597299A2 Carbonate esters of polyethylene glycol activated by means of oxalate esters |
| 11/23/2005 | EP1597282A2 ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-1 beta |
| 11/23/2005 | EP1597278A2 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 11/23/2005 | EP1596887A2 Polymer-factor viii moiety conjugates |
| 11/23/2005 | EP1596863A2 Pharmaceutical compositions for nasal delivery |
| 11/23/2005 | EP1596823A2 A stable ophthalmic composition |
| 11/23/2005 | EP1596822A2 A low dose corticosteroid composition |
| 11/23/2005 | EP1596821A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 11/23/2005 | EP1596815A2 Composition and methods for inhibiting cell survival |
| 11/23/2005 | EP1596812A2 Bioadhesive liquid composition which is substantially free of water |
| 11/23/2005 | EP1596767A2 Random and non-random alkylene oxide polymer alloy compositions |
| 11/23/2005 | EP1596756A2 Absorption enhancing agents |
| 11/23/2005 | EP1596671A1 Chitosan foodstuff |
| 11/23/2005 | EP1467718B1 Method of treatment of a patient requiring analgesia |
| 11/23/2005 | EP1423151A4 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 11/23/2005 | EP1377227B1 Vessel sealing instrument |
| 11/23/2005 | EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 11/23/2005 | EP1294513A4 Site-specific, covalent bioconjugation of proteins |
| 11/23/2005 | EP1267941B1 Alprazolam inclusion complexes and pharmaceutical compositions thereof |
| 11/23/2005 | EP1267846B1 Transdermal therapeutic system for the delivery of lerisetron |
| 11/23/2005 | EP1263802B1 Hydrogel biomedical articles |
| 11/23/2005 | EP1258249B1 Oral preparations for diabetes |
| 11/23/2005 | EP1194161B1 Stable factor viii compositions |
| 11/23/2005 | EP1140028B1 Biodegradable poly(phosphoester) compositions for treating ovarian cancer |
| 11/23/2005 | EP1137401B1 Administration of neurotrophic agents to the central nervous system |
| 11/23/2005 | EP1117385B1 Aqueous enteric coating composition with low gastric permeability |
| 11/23/2005 | EP1117383B1 Dosage form comprising therapeutic formulation |
| 11/23/2005 | EP1102601B1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 11/23/2005 | EP1082102B1 Biologically active composition |
| 11/23/2005 | EP1058547B1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 11/23/2005 | EP1041973B1 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
| 11/23/2005 | EP1007060B1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
| 11/23/2005 | EP0895784B1 Drug complexes comprising taxane compounds or steroids |
| 11/23/2005 | EP0778780B1 Capsular polysaccharide immunomodulator |
| 11/23/2005 | CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 11/23/2005 | CN1700913A Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 11/23/2005 | CN1698903A High molecular antineoplastic cisplatin medicine and preparation method thereof |
| 11/23/2005 | CN1698902A Reversal temperature sensitive injection type implantable drug supporter material |
| 11/23/2005 | CN1698901A Chitosan or its derivative as drug carrier for carrying red sage root extract |
| 11/23/2005 | CN1698900A Chitosan drug carrying microsphere with uniform size, high embedding rate and high drug activity maintaining rate and its preparation process |
| 11/23/2005 | CN1698899A Novel pharmaceutical composition using chitosan or its derivatives as drug carrier |
| 11/23/2005 | CN1698898A Biodegradation type eye implantation agent |
| 11/23/2005 | CN1698897A Pharmaceutical aerosol prepared by trifluorodichloroethane instead of trichlorofluoromethane |
| 11/23/2005 | CN1698580A Sustained release formulations for parenteral administration and process of preparation |
| 11/23/2005 | CN1698567A A method of anti-counterfeit marking a product which is manufactured with a stable non-radioactive isotope |
| 11/23/2005 | CN1228044C Water-soluble medicine particle-type slow-release composition, preparation and its preparing method |
| 11/23/2005 | CN1228043C Sustained release groundmass for highly soluble drugs |
| 11/23/2005 | CN1228041C Methods for preparation of lipid-encapsulated therapeutic agents |
| 11/22/2005 | US6967089 Delivery system for porcine somatotropin |
| 11/22/2005 | US6967026 Hard capsule filled with drug and polyethylene glycol |
| 11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 11/22/2005 | US6967022 Ganglioside-KLH conjugate vaccines plus QS-21 |
| 11/22/2005 | CA2378894C Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 11/22/2005 | CA2304722C Acidic addition salts of morphine alkaloids and the application thereof |
| 11/22/2005 | CA2260845C Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
| 11/22/2005 | CA2258918C Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 11/22/2005 | CA2249336C Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 11/22/2005 | CA2244767C Process for the production of powdered pulmonary surfactant preparations |
| 11/22/2005 | CA2154164C Excipient stabilization of polypeptides treated with organic solvents |
| 11/22/2005 | CA2109697C Oral-administration forms of a medicament containing pantoprazole |
| 11/22/2005 | CA2080353C Unimolecular micelles and method of making the same |
| 11/17/2005 | WO2005108464A1 Materials having crosslinked polyrotaxane and process for producing these |
| 11/17/2005 | WO2005108463A2 Branched polyethylen glycol derivates comprising an acetal or ketal branching point |
| 11/17/2005 | WO2005108418A1 Compounds for specific viral target |
| 11/17/2005 | WO2005107817A2 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 11/17/2005 | WO2005107815A2 Polymer derivatives comprising an imide branching point |